PT819122E - Derivados de 1,3-di-hidro-1-(fenilalquil)-2h-imidazol-2-ona com actividade de pde iv e de citoquina - Google Patents

Derivados de 1,3-di-hidro-1-(fenilalquil)-2h-imidazol-2-ona com actividade de pde iv e de citoquina

Info

Publication number
PT819122E
PT819122E PT96909150T PT96909150T PT819122E PT 819122 E PT819122 E PT 819122E PT 96909150 T PT96909150 T PT 96909150T PT 96909150 T PT96909150 T PT 96909150T PT 819122 E PT819122 E PT 819122E
Authority
PT
Portugal
Prior art keywords
phenylalquil
ona
pde
cytokine
dihydro
Prior art date
Application number
PT96909150T
Other languages
English (en)
Inventor
Gaston Stanislas Marcell Diels
Eddy Jean Edgard Freyne
Jose Ignacio Vesubi Andres-Gil
Francisco Javi Fernandez-Gadea
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PT819122E publication Critical patent/PT819122E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/36—One oxygen atom with hydrocarbon radicals, substituted by nitrogen atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/38—One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT96909150T 1995-04-06 1996-03-28 Derivados de 1,3-di-hidro-1-(fenilalquil)-2h-imidazol-2-ona com actividade de pde iv e de citoquina PT819122E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95200868 1995-04-06
EP95202898 1995-10-26

Publications (1)

Publication Number Publication Date
PT819122E true PT819122E (pt) 2002-08-30

Family

ID=26139205

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96909150T PT819122E (pt) 1995-04-06 1996-03-28 Derivados de 1,3-di-hidro-1-(fenilalquil)-2h-imidazol-2-ona com actividade de pde iv e de citoquina

Country Status (27)

Country Link
US (2) US5994376A (pt)
EP (1) EP0819122B1 (pt)
JP (1) JP4562101B2 (pt)
KR (1) KR100406628B1 (pt)
CN (1) CN1068591C (pt)
AR (1) AR002732A1 (pt)
AT (1) ATE214052T1 (pt)
AU (1) AU702947B2 (pt)
CA (1) CA2216653C (pt)
CY (1) CY2328B1 (pt)
CZ (1) CZ293127B6 (pt)
DE (1) DE69619661T2 (pt)
DK (1) DK0819122T3 (pt)
ES (1) ES2174064T3 (pt)
HK (1) HK1007880A1 (pt)
HR (1) HRP960155A2 (pt)
HU (1) HU223324B1 (pt)
IL (1) IL117807A (pt)
MX (1) MX9707652A (pt)
MY (1) MY119254A (pt)
NO (1) NO314339B1 (pt)
NZ (1) NZ304877A (pt)
PL (1) PL187375B1 (pt)
PT (1) PT819122E (pt)
SI (1) SI0819122T1 (pt)
TW (1) TW332201B (pt)
WO (1) WO1996031485A1 (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703098A (en) * 1994-12-30 1997-12-30 Celgene Corporation Immunotherapeutic imides/amides
TW332201B (en) 1995-04-06 1998-05-21 Janssen Pharmaceutica Nv 1,3-Dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatives
ATE236884T1 (de) * 1996-10-02 2003-04-15 Janssen Pharmaceutica Nv Pde-iv hemmende 2-cyanoiminoimidazol-derivate
ID24224A (id) * 1997-07-10 2000-07-13 Janssen Pharmaceutica Nv Turunan-turunan 6-azaurasil sebagai inhibitor il-5
US6017926A (en) * 1997-12-17 2000-01-25 Merck & Co., Inc. Integrin receptor antagonists
TR200002801T2 (tr) * 1998-04-01 2000-12-21 Janssen Pharmaceutica N.V. PDE IV engelleyici piridin türevleri
US6118017A (en) * 1998-04-14 2000-09-12 Smithkline Beecham Corporation Substituted-(3-cyclopentyloxy-4-methoxyphenyl)-3-phenylcyanocyclobutan-1-one
JP2002511438A (ja) * 1998-04-14 2002-04-16 スミスクライン・ビーチャム・コーポレイション ホスホジエステラーゼアイソザイム４（ｐｄｅ４）の阻害性化合物
DE69907254T2 (de) 1998-11-23 2004-04-01 Janssen Pharmaceutica N.V. 6-azauracilderivate als il-5 inhibitoren
EA004806B1 (ru) 1998-12-18 2004-08-26 Янссен Фармацевтика Н.В. Производные 6-азаурацила, ингибирующие il-5
EP1322310A4 (en) * 2000-09-13 2004-09-15 Merck & Co Inc ALPHA V INTEGRIN RECEPTOR ANTAGONISTS
JP4510383B2 (ja) * 2001-05-23 2010-07-21 田辺三菱製薬株式会社 軟骨疾患修復治療用組成物
US20040146561A1 (en) 2001-05-23 2004-07-29 Naoki Sakurai Compositions for promoting healing of bone fracture
US6706739B2 (en) * 2001-08-21 2004-03-16 National Health Research Institute Imidazolidinone compounds
SE0200667D0 (sv) * 2002-03-05 2002-03-05 A & Science Invest Ab Novel use of cytokine inhibitors
GB0326407D0 (en) * 2003-11-12 2003-12-17 Glaxo Group Ltd Chemical compounds
GB0412865D0 (en) * 2004-06-09 2004-07-14 Glaxo Group Ltd Chemical compounds
US20080200526A1 (en) * 2004-07-05 2008-08-21 Jin Soo Lee Composition for the Prevention and Treatment of Allergic Inflammatory Disease
AR057455A1 (es) * 2005-07-22 2007-12-05 Merck & Co Inc Inhibidores de la transcriptasa reversa de vih y composicion farmaceutica
US8354434B2 (en) * 2006-01-30 2013-01-15 Purdue Pharma L.P. Cyclourea compounds as calcium channel blockers
EP1834953A1 (en) 2006-03-14 2007-09-19 Ranbaxy Laboratories Limited Tetrahydropyrane derivatives as 5-lipoxygenase inhibitors
US7390772B2 (en) * 2006-05-18 2008-06-24 International Flavor & Fragrances Inc. 1-phenyl-spiro[2.5]octane-1-carbonitrile analogues their use in fragrance formulations
WO2008157425A2 (en) * 2007-06-14 2008-12-24 The Regents Of The University Of California Compounds for inhibiting protein aggregation, and methods for making and using them
NZ601967A (en) * 2010-03-12 2015-03-27 Omeros Corp Pde10 inhibitors and related compositions and methods
NZ630810A (en) 2014-04-28 2016-03-31 Omeros Corp Processes and intermediates for the preparation of a pde10 inhibitor
NZ716462A (en) 2014-04-28 2017-11-24 Omeros Corp Optically active pde10 inhibitor
EP3285760A4 (en) 2015-04-24 2018-09-26 Omeros Corporation Pde10 inhibitors and related compositions and methods
JP2018535969A (ja) 2015-11-04 2018-12-06 オメロス コーポレーション Ｐｄｅ１０阻害剤の固体状態形態

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL285394A (pt) * 1961-11-17
US3184060A (en) 1963-02-13 1965-05-18 Owens Illinois Glass Co Packaging tacky latex emulsion paints in containers manufactured from polyolefinic maerials
WO1992007567A1 (en) * 1990-11-06 1992-05-14 Smithkline Beecham Corporation Imidazolidinone compounds
ATE234270T1 (de) * 1992-12-02 2003-03-15 Pfizer Cathecoldiether als selektive pde iv hemmungsmittel
TW263495B (pt) * 1992-12-23 1995-11-21 Celltech Ltd
GB9304920D0 (en) * 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
TW332201B (en) 1995-04-06 1998-05-21 Janssen Pharmaceutica Nv 1,3-Dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatives

Also Published As

Publication number Publication date
HUP9801575A2 (hu) 1999-01-28
MX9707652A (es) 1997-11-29
US20020068830A1 (en) 2002-06-06
HU223324B1 (hu) 2004-06-28
JPH11503136A (ja) 1999-03-23
CA2216653A1 (en) 1996-10-10
AU5275596A (en) 1996-10-23
WO1996031485A1 (en) 1996-10-10
SI0819122T1 (en) 2002-06-30
EP0819122A1 (en) 1998-01-21
IL117807A (en) 2001-06-14
AR002732A1 (es) 1998-04-29
CN1181072A (zh) 1998-05-06
DE69619661T2 (de) 2002-10-31
HRP960155A2 (en) 1997-10-31
CN1068591C (zh) 2001-07-18
DK0819122T3 (da) 2002-07-01
IL117807A0 (en) 1996-08-04
PL322654A1 (en) 1998-02-16
JP4562101B2 (ja) 2010-10-13
CA2216653C (en) 2009-05-26
US5994376A (en) 1999-11-30
NO974602D0 (no) 1997-10-06
NO314339B1 (no) 2003-03-10
CY2328B1 (en) 2004-02-06
HK1007880A1 (en) 1999-04-30
DE69619661D1 (de) 2002-04-11
CZ293127B6 (cs) 2004-02-18
AU702947B2 (en) 1999-03-11
US6403805B1 (en) 2002-06-11
NZ304877A (en) 1999-06-29
ATE214052T1 (de) 2002-03-15
ES2174064T3 (es) 2002-11-01
CZ314997A3 (cs) 1998-12-16
HUP9801575A3 (en) 1999-03-01
NO974602L (no) 1997-10-06
MY119254A (en) 2005-04-30
TW332201B (en) 1998-05-21
KR100406628B1 (ko) 2004-05-31
EP0819122B1 (en) 2002-03-06
KR19980703449A (ko) 1998-11-05
PL187375B1 (pl) 2004-06-30

Similar Documents

Publication Publication Date Title
PT819122E (pt) Derivados de 1,3-di-hidro-1-(fenilalquil)-2h-imidazol-2-ona com actividade de pde iv e de citoquina
DE68929305D1 (de) Oligoribonukleotid-Derivate und Verwendung davon als Antiviral Arzneimittel
NO308740B1 (no) Kinazolinderivater, anvendelse derav og farmasøytisk blanding
DE69629988D1 (de) Pharmazeutisches Grundbestandteil und seine Verwendung
HK1012193A1 (en) Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives
ATE380794T1 (de) 1,3-dihydro-1-(phenylalkenyl)-2h-imidazol-2 on- derivate mit pde iv und cytokin-inhibirendes aktivität
MX9203459A (es) Nuevos derivados de 2'-halometilideno, 2'-etenilideno y 2'-etinilcitidina, uridina y guanosina.
DE68918215D1 (de) 2'-Halomethyliden, 2'-Ethenyliden und 2'-Ethynyl-Adenosinderivate.
MA22916A1 (fr) Derives de 2-imidazoline-5-ones et 2-imidazoline-5-thiones fongicides.
NO960699L (no) Antimigren 1,2,5-tiadiazolderivater av indolylalkylpyridinyl- og -pyrimidinylpiperaziner
PL327686A1 (en) Derivatives of @-amino 5,6-dichlorobenzimidazole exhibiting antiviral activity
ATE305455T1 (de) 1,3-dihydro-2h-imidazol-2-on-derivate mit pdeiv und cytokin inhibierender aktivität
FR2735776B1 (fr) Derives de 2,3-dihydro-1h-indole, leur preparation et leur application en therapeutique
FR2731707B1 (fr) Derives de benzimidazole, leur preparation et leur application en therapeutique
DE4493151T1 (de) Pyrimidinderivate und Arzneimittel
FR2738567B1 (fr) Derives de alpha-phenylpiperidine-1-propanol, leur preparation et leur application en therapeutique
BR9508669A (pt) Novos derivados de taizoloÚ3,2-a¾quinolina e naftirina
IT1275866B1 (it) Derivati oligonucleotidici ad attivita' farmacologica e procedimento per la loro preparazione
MX9203071A (es) Derivados de fenetilaminea y tritptofano-fenilalanina-n n-cicloalquil substituidos y policicloalquil alfa-substituidos.
HUP9903260A3 (en) 2,4-diaminopyrimidine derivatives with antibiotic activity, preparation and use thereof
FR2739858B1 (fr) Derives de n-sulfonyl- et n-sulfamoylpeptidylprolinamide, leur preparation et leur application en therapeutique
MX15190A (es) Complejo de derivados de telurio y silenio.